Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-397
Closed -$15K 912
2022
Q3
$15K Hold
397
﹤0.01% 476
2022
Q2
$20K Sell
397
-56
-12% -$2.97K ﹤0.01% 420
2022
Q1
$23K Hold
453
﹤0.01% 398
2021
Q4
$23K Buy
453
+45
+11% +$2.23K ﹤0.01% 412
2021
Q3
$20K Hold
408
﹤0.01% 416
2021
Q2
$21K Buy
408
+148
+57% +$7.72K ﹤0.01% 397
2021
Q1
$13K Sell
260
-68
-21% -$3.27K ﹤0.01% 462
2020
Q4
$16K Hold
328
﹤0.01% 430
2020
Q3
$16K Hold
328
﹤0.01% 375
2020
Q2
$17K Buy
328
+80
+32% +$3.89K ﹤0.01% 373
2020
Q1
$11K Buy
+248
New +$11.9K ﹤0.01% 414
2019
Q2
Sell
-860
Closed -$38K 879
2019
Q1
$38K Buy
+860
New +$36.8K 0.01% 310
2017
Q2
Sell
-47
Closed -$2K 1015
2017
Q1
$2K Hold
47
﹤0.01% 863
2016
Q4
$2K Buy
+47
New +$1.85K ﹤0.01% 889
2016
Q3
Sell
-715
Closed -$30K 1112
2016
Q2
$30K Hold
715
0.01% 287
2016
Q1
$29K Buy
+715
New +$28.7K 0.01% 347
2014
Q2
Sell
-1,376
Closed -$72K 919
2014
Q1
$72K Buy
1,376
+611
+80% +$30.9K 0.02% 261
2013
Q4
$41K Sell
765
-626
-45% -$32.3K 0.01% 323
2013
Q3
$71K Sell
1,391
-477
-26% -$24.3K 0.03% 253
2013
Q2
$96K Buy
+1,868
New +$99.5K 0.03% 222

Other funds holding SNY

Howe & Rusling's SNY Position: Q4 2022 in Review

Howe & Rusling sold out of Sanofi (SNY) in Q4 2022, closing a stake of 397 shares — an estimated $15K sold.

Howe & Rusling first reported a position in SNY in Q2 2013 and held it in 20 quarters. The position peaked at $96K in Q2 2013. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

  • Howe & Rusling reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 397 Sanofi shares in Q4 2022, an estimated $15K.
  • Howe & Rusling first reported a position in Sanofi in Q2 2013 and held it in 20 quarters.
  • Howe & Rusling's Sanofi position peaked at $96K in Q2 2013.
  • 643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.